HUM450.00+6.32 (+1.42%) session● PRIOR SESSION CLOSE

HUMcited research thesis

HUM — what changed and why it matters

House verdict · HUM · multi-desk debate + self-falsification

No sealed verdict on HUM yet

No debate has been run on HUM; debates rotate through a watchlist. The conviction call below is the signal engine’s output — one input to a debate, not a multi-desk verdict. Sealed debates on other names, each with its falsification check, are available.
Open the Glass Box →
Individual · $49 a monthThe conviction call on HUM — outside the public coverage list

Covered names include the conviction call in the sealed record at no charge. HUM is outside public coverage; running the signal engine on it requires a seat. The panels above do not depend on it.

Start checkout →

PRE-EARNINGS THESIS — written 2026-07-27, before the 2026-11-06 earnings report; nothing below reflects that report. A refresh is queued for the session a covered name reports or moves sharply. A same-session re-derive is queued when a covered name prints or moves sharply; until the refreshed read lands, nothing below reflects that report.

synthetic0 of 17 figures below re-derived from a sourcewritten 2026-07-27

This thesis is 109 days old. Statements below are as of 2026-07-27.

HUM — what moved and why today

Context (knowledge graph)

AtlasVector tracks 21 related entities for HUM in its knowledge graph. [c1]

Catalyst confluence

  • Catalyst

What changed

  • Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)
  • The Real Price of UnitedHealth Stock Is Two Years Away
  • Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

Valuation spine (rich/cheap)

Rich/cheap deviation: 1.5473. Conviction signal: 0.775. [c6]

Key takeaways
  • Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)
  • The Real Price of UnitedHealth Stock Is Two Years Away
  • Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
Headlines · HUM AS OF 2026-11-14 02:21Z
  1. 11-11 17:13ZCan HUM's New Oncology Model Strengthen Its Value-Based Care Strategy?Zacks Investment Research
  2. 11-11 16:00ZHumana (HUM) Upgraded to Strong Buy: Here's WhyZacks Investment Research
  3. 11-06 17:27ZHUM Q3 Earnings Beat Estimates on Strong Insurance PerformanceZacks Investment Research
  4. 11-06 11:30ZHumana (HUM) Reports Q3 Loss, Beats Revenue EstimatesZacks Investment Research
  5. 11-10 18:43ZShould Invesco S&P 500 Pure Value ETF (RPV) Be on Your Investing Radar?Zacks Investment Research
  6. 11-06 14:29ZGreat Jobs Report. Will It Matter to Market Participants?Zacks Investment Research

Provenance

verdicts, debates and hash-chained audit seals recorded against HUM
Instruments 1
  • HUM2026-11-12
Session bars 5
  • HUM · Thu Nov 12 session barHUM2026-11-12
  • HUM · Wed Nov 11 session barHUM2026-11-11
  • HUM · Tue Nov 10 session barHUM2026-11-10
  • HUM · Mon Nov 09 session barHUM2026-11-09
  • HUM · Thu Oct 29 session barHUM2026-10-29
Screen metrics 1
  • HUM · screen metrics · Thu Nov 12HUM2026-11-12

7 recorded entities · 6 links. synthetic = the row is flagged as built on synthetic inputs; no provenance = the store holds no synthetic flag for the row. Unmarked rows are flagged non-synthetic. Chain seals list sequence number, event key and SHA-256 chain hash. Verify seal opens the verdict's proof panel, where the sealed record is re-hashed in the browser and compared against the seal.

Cited sources · 6

[c1]AtlasVector knowledge graphgraph context for HUM
[c2]CatalystCatalyst
[c3]NewswireEarn 10-15% Potential Income: Monthly Options Series (Aug. 2026)
[c4]NewswireThe Real Price of UnitedHealth Stock Is Two Years Away
[c5]NewswireCan Humana Beat Q2 Earnings Estimates on Growing Premiums?
[c6]AtlasVector valuation spineconsensus valuation

The full record is in AtlasVector.

Standing monitors, multi-desk debate, audited paper trading and a persistent research record.

Open AtlasVector →